相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Effect of p53 and its N-terminally truncated isoform, Δ40p53, on breast cancer migration and invasion
Xiajie Zhang et al.
MOLECULAR ONCOLOGY (2022)
DNA-Damage-Induced Alternative Splicing of p53
Jing Chen et al.
CANCERS (2021)
p53 isoforms differentially impact on the POLι dependent DNA damage tolerance pathway
Yitian Guo et al.
CELL DEATH & DISEASE (2021)
Altered Expression of Shorter p53 Family Isoforms Can Impact Melanoma Aggressiveness
Ana Tadijan et al.
CANCERS (2021)
Δ133p53β isoform pro-invasive activity is regulated through an aggregation-dependent mechanism in cancer cells
Nikola Arsic et al.
NATURE COMMUNICATIONS (2021)
The Δ40p53 isoform inhibits p53-dependent eRNA transcription and enables regulation by signal-specific transcription factors during p53 activation
Cecilia B. Levandowski et al.
PLOS BIOLOGY (2021)
Δ133p53α enhances metabolic and cellular fitness of TCR-engineered T cells and promotes superior antitumor immunity
Kevin Jan Legscha et al.
JOURNAL FOR IMMUNOTHERAPY OF CANCER (2021)
Expression of p53 N-terminal isoforms in B-cell precursor acute lymphoblastic leukemia and its correlation with clinicopathological profiles
Lixian Oh et al.
BMC CANCER (2020)
P53: A Guardian of Immunity Becomes Its Saboteur through Mutation
Arjelle Decasa Agupitan et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2020)
Good Cop, Bad Cop: Defining the Roles of Δ40p53 in Cancer and Aging
Luiza Steffens Reinhardt et al.
CANCERS (2020)
Intronic TP53 Polymorphisms Are Associated with Increased Δ133TP53 Transcript, Immune Infiltration and Cancer Risk
Ramona A. Eiholzer et al.
CANCERS (2020)
The p53 mRNA: an integral part of the cellular stress response
Lucia Haronikova et al.
NUCLEIC ACIDS RESEARCH (2019)
Loss of the p53 transactivation domain results in high amyloid aggregation of the 40p53 isoform in endometrial carcinoma cells
Nataly Melo dos Santos et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2019)
The Δ133p53β isoform promotes an immunosuppressive environment leading to aggressive prostate cancer
Marina Kazantseva et al.
CELL DEATH & DISEASE (2019)
Translational Control in p53 Expression: The Role of 5′-Terminal Region of p53 mRNA
Agata Swiatkowska et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2019)
Conformational stability and dynamics of the cancer-associated isoform 133p53 are modulated by p53 peptides and p53-specific DNA
Jiangtao Lei et al.
FASEB JOURNAL (2019)
Integrated tumor identification and automated scoring minimizes pathologist involvement and provides new insights to key biomarkers in breast cancer
Peter Bankhead et al.
LABORATORY INVESTIGATION (2018)
Elevation of the TP53 isoform Δ133p53β in glioblastomas: an alternative to mutant p53 in promoting tumor development
Marina Kazantseva et al.
JOURNAL OF PATHOLOGY (2018)
A mouse model of the 133p53 isoform: roles in cancer progression and inflammation
Marina Kazantseva et al.
MAMMALIAN GENOME (2018)
Delta 133p53 isoform promotes tumour invasion and metastasis via interleukin-6 activation of JAK-STAT and RhoA-ROCK signalling
Hamish Campbell et al.
NATURE COMMUNICATIONS (2018)
High Densities of Tumor-Associated Plasma Cells Predict Improved Prognosis in Triple Negative Breast Cancer
Joe Yeong et al.
FRONTIERS IN IMMUNOLOGY (2018)
The p53 isoform delta133p53β regulates cancer cell apoptosis in a RhoB-dependent manner
Nikola Arsic et al.
PLOS ONE (2017)
Post-translational regulation of p53 function through 20S proteasome-mediated cleavage
Hilla Solomon et al.
CELL DEATH AND DIFFERENTIATION (2017)
The presence of the intron 3 16 bp duplication polymorphism of p53 (rs17878362) in breast cancer is associated with a low Δ40p53:p53 ratio and better outcome
Brianna C. Morten et al.
CARCINOGENESIS (2016)
Role of p53 isoforms and aggregations in cancer
SeJin Kim et al.
MEDICINE (2016)
Comparison of the QuantiGene 2.0 Assay and Real-Time RT-PCR in the Detection of p53 Isoform mRNA Expression in Formalin-Fixed Paraffin-Embedded Tissues-A Preliminary Study
Brianna C. Morten et al.
PLOS ONE (2016)
TP53 drives invasion through expression of its Δ133p53β variant
Gilles Gadea et al.
ELIFE (2016)
Emerging roles of p53 and other tumour-suppressor genes in immune regulation
Cesar Munoz-Fontela et al.
NATURE REVIEWS IMMUNOLOGY (2016)
Relationship between differentially expressed mRNA and mRNA-protein correlations in a xenograft model system
Antonis Koussounadis et al.
SCIENTIFIC REPORTS (2015)
The p53 Isoform Δ133p53β Promotes Cancer Stem Cell Potential
Nikola Arsic et al.
STEM CELL REPORTS (2015)
The relative mRNA expression of p53 isoforms in breast cancer is associated with clinical features and outcome
Kelly A. Avery-Kiejda et al.
CARCINOGENESIS (2014)
Dominant Effects of Δ40p53 on p53 Function and Melanoma Cell Fate
Rie Takahashi et al.
JOURNAL OF INVESTIGATIVE DERMATOLOGY (2014)
The translation initiation factor DAP5 promotes IRES-driven translation of p53 mRNA
S. Weingarten-Gabbay et al.
ONCOGENE (2014)
Dual roles for immune metagenes in breast cancer prognosis and therapy prediction
Angela Alistar et al.
GENOME MEDICINE (2014)
IRES mediated translational regulation of p53 isoforms
Arandkar Sharathchandra et al.
WILEY INTERDISCIPLINARY REVIEWS-RNA (2014)
Prognostic evaluation of the B cell/IL-8 metagene in different intrinsic breast cancer subtypes
Lars C. Hanker et al.
BREAST CANCER RESEARCH AND TREATMENT (2013)
The relationship between lymphocyte subsets and clinico-pathological determinants of survival in patients with primary operable invasive ductal breast cancer
Z. M. A. Mohammed et al.
BRITISH JOURNAL OF CANCER (2013)
p53 isoforms regulate aging- and tumor-associated replicative senescence in T lymphocytes
Abdul M. Mondal et al.
JOURNAL OF CLINICAL INVESTIGATION (2013)
p53 isoform profiling in glioblastoma and injured brain
R. Takahashi et al.
ONCOGENE (2013)
The impact of p53 in predicting clinical outcome of breast cancer patients with visceral metastasis
P. Yang et al.
SCIENTIFIC REPORTS (2013)
The N-Terminally Truncated p53 Isoform Δ40p53 Influences Prognosis in Mucinous Ovarian Cancer
Gerda Hofstetter et al.
INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER (2012)
Comprehensive molecular portraits of human breast tumours
Daniel C. Koboldt et al.
NATURE (2012)
Insights into the regulation of protein abundance from proteomic and transcriptomic analyses
Christine Vogel et al.
NATURE REVIEWS GENETICS (2012)
Annexin A2 and PSF proteins interact with p53 IRES and regulate translation of p53 mRNA
Arandkar Sharathchandra et al.
RNA BIOLOGY (2012)
p53 mutant breast cancer patients expressing p53 gamma have as good a prognosis as wild-type p53 breast cancer patients
Jean-Christophe Bourdon et al.
BREAST CANCER RESEARCH (2011)
p53 as a Marker of Prognosis in African-American Women with Breast Cancer
Keith A. Dookeran et al.
ANNALS OF SURGICAL ONCOLOGY (2010)
Δ160p53 is a novel N-terminal p53 isoform encoded by Δ133p53 transcript
Virginie Marcel et al.
FEBS LETTERS (2010)
Δ40p53 controls the switch from pluripotency to differentiation by regulating IGF signaling in ESCs
Erica Ungewitter et al.
GENES & DEVELOPMENT (2010)
Regulation of tumor suppressor p53 at the RNA level
Anna Vilborg et al.
JOURNAL OF MOLECULAR MEDICINE-JMM (2010)
Endoplasmic Reticulum Stress Induces G2 Cell-Cycle Arrest via mRNA Translation of the p53 Isoform p53/47
Karima Bourougaa et al.
MOLECULAR CELL (2010)
Alternative splicing of p53 and p73: the novel p53 splice variant p53δ is an independent prognostic marker in ovarian cancer
G. Hofstetter et al.
ONCOGENE (2010)
TP53 Mutations in Human Cancers: Origins, Consequences, and Clinical Use
Magali Olivier et al.
COLD SPRING HARBOR PERSPECTIVES IN BIOLOGY (2010)
Correlation of mRNA and protein in complex biological samples
Tobias Maier et al.
FEBS LETTERS (2009)
Global signatures of protein and mRNA expression levels
Raquel de Sousa Abreu et al.
MOLECULAR BIOSYSTEMS (2009)
p53 isoforms Δ133p53 and p53β are endogenous regulators of replicative cellular senescence
Kaori Fujita et al.
NATURE CELL BIOLOGY (2009)
The humoral immune system has a key prognostic impact in node-negative breast cancer
Marcus Schmidt et al.
CANCER RESEARCH (2008)
Stress-dependent changes in the properties of p53 complexes by the alternative translation product p53/47
Darren J. Powell et al.
CELL CYCLE (2008)
Polypyrimidine tract binding protein regulates IRES-mediated translation of p53 isoforms
Richa Grover et al.
CELL CYCLE (2008)
Small molecular weight variants of p53 are expressed in human melanoma cells and are induced by the DNA-damaging agent cisplatin
Kelly A. Avery-Kiejda et al.
CLINICAL CANCER RESEARCH (2008)
Expression of p53 and p53/47 are controlled by alternative mechanisms of messenger RNA translation initiation
M. M. Candeias et al.
ONCOGENE (2006)
A distinct p53 protein isoform signature reflects the onset of induction chemotherapy for acute myeloid leukemia
Nina Anensen et al.
CLINICAL CANCER RESEARCH (2006)
Two internal ribosome entry sites mediate the translation of p53 isoforms
PS Ray et al.
EMBO REPORTS (2006)
p53 isoforms can regulate p53 transcriptional activity
JC Bourdon et al.
GENES & DEVELOPMENT (2005)
Regulation of human p53 activity and cell localization by alternative splicing
A Ghosh et al.
MOLECULAR AND CELLULAR BIOLOGY (2004)
ΔN-p53, a natural isoform of p53 lacking the first transactivation domain, counteracts growth suppression by wild-type p53
S Courtois et al.
ONCOGENE (2002)
分享论文
